Latest Articles

Dr. Jenna Macciochi is a lecturer in immunology at the University of Sussex, where her research centers on understanding the role that nutrition and lifestyle play in human immunity. Technology Networks sat down with Dr. Macciochi to ask: how can we really stay well? What has immunological research taught us about the effects of modern lifestyle on our bodies and what are some of the latest breakthroughs in this field?

Recently, an expose article was published revealing a potential fabrication of data by prominent investigators of Alzheimer’s disease. In this op-ed piece, Michael Kinch explores the catastrophic impact of scientific fraud.

The Binomial test, sometimes referred to as the Binomial exact test, is a test used in sampling statistics to assess whether a proportion of a binary variable is equal to some hypothesized value. In this article, we explore the key features of this test and walk through an example test.

Here we explore how biomarkers are driving the immuno-oncology landscape. We dive into cutting-edge biomarker research and the challenges facing the field.

CRISPR screening enables the rapid and unbiased identification of genes relevant to a specific biological pathway. In this article, we explore how researchers are using this cutting-edge tool to shape our understanding of biology and advance medicine.

This article describes the background and potential of the emerging field of glycoproteomics.

This article explores the potential for innovative diagnostics and a precision medicine approach to improve treatment for rheumatoid arthritis patients.

In this article, we will describe what benign and malignant tumors are, explore the similarities and differences between the two types of tumors and discuss if benign tumors can become malignant.

Dr. Alexandra Freeman believes that the major problems associated with research culture in science can be traced back to one source: the current scientific publishing model. In this interview with Technology Networks, she explains why a novel approach, called Octopus, is a logical solution to these issues.

This article will discuss advances in fragment-based drug discovery and will highlight some examples of recent successes in this area.